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Abstract Intraoperative detection of sentinel node metastases in breast cancer
enables immediate axillary lymph node dissection. This approach, however, intro-
duces uncertainty for patients as to the extent of surgery. Waking to find a surgical
drain implies more extensive surgery and worse prognosis disease. False negative
diagnoses may cause disappointment.
Aim: To evaluate patients’ views and preferences on intraoperative diagnosis
of sentinel nodes in breast cancer.
Methods: Questionnaire based survey of 100 patients who had previously undergone
sentinel node biopsy with intraoperative diagnosis using touch imprint cytology
(TIC). Patients were encouraged to add free text comments.
Results: Sixty-four patients responded to the questionnaire. Patients rated the
information provided and their understanding of the procedure highly. Fifty-nine
percent of respondents overestimated the sensitivity of TIC. Ninety-five percent
of patients would choose to undergo intraoperative diagnosis in future if required.
Five percent of patients would choose not to undergo intraoperative diagnosis,
citing the resultant uncertainty, disappointment on waking and needing time to
come in terms with the diagnosis of metastases as reasons.
Conclusion: Given the choice, most patients would choose intraoperative diagnosis,
though a minority would explicitly not, due to the adverse psychological effect
thereof. Despite a good understanding of the procedure, the majority of patients
overestimate the sensitivity of intraoperative diagnosis of sentinel nodes, which
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tive diagnosis should not be the automatic choice and patients should be actively
involved in this decision making process.
ª 2006 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.Introduction
Sentinel node biopsy has emerged as a standard of
care for nodal staging of breast cancer. Intra-
operative diagnosis of sentinel nodes enables an
immediate decision to proceed to completion
axillary lymph node dissection (ALND), where in-
dicated. From the patients’ perspective, intra-
operative diagnosis introduces an uncertainty
over the operative procedure, since on induction
of anaesthesia, the extent of surgery they are to
undergo is not known. Waking with a surgical drain
implies both a more extensive surgical procedure
(ALND) and worse prognosis (node-positive) dis-
ease. Furthermore, even the most intensive intra-
operative examination has a false negative rate,
which results in a proportion of patients still
requiring delayed completion ALND. For these
patients, initial post-operative elation is replaced
by disappointment.
While many clinicians believe that intraopera-
tive diagnosis is advantageous, little is known
about patients’ views and preferences.
Aim
To evaluate patients’ views and preferences of
intraoperative diagnosis of sentinel lymph nodes
in breast cancer.
Methods
After obtaining ethical approval, we conducted
a questionnaire based survey of 100 consecutive
patients who underwent sentinel node biopsy for
breast carcinoma within the preceding 18 months.
All patients had undergone intraoperative diagno-
sis of sentinel nodes utilizing touch imprint cytol-
ogy (TIC). The sensitivity of TIC in our institution is
81% with 100% specificity. This information was
provided both verbally and on an information
sheet with particular emphasis on the false nega-
tive rate. All patients with a positive (metastatic)
TIC underwent immediate axillary lymph node
dissection. Patients with a negative (normal) TIC
who were subsequently found to have metastaseson haematoxylin and eosin stained sections, were
offered completion ALND as a second operative
procedure.
The questionnaire comprised 10 questions and
patients were encouraged to add free text com-
ments to all sections of the questionnaire. Five
questions evaluated patients’ understanding of the
extent of the operative procedure performed.
Patients’ perception of the sensitivity of the intra-
operative diagnostic test was evaluated with
a multiple choice question. Patients were asked
to rate the information provided pre-operatively
and their understanding of the surgery performed
on a scale of 0e10 (0¼ poor, 10¼ excellent).
Finally patients were asked to score their prefer-
ence for intraoperative diagnosis aiming for a one
stage operation or standard histological diagnosis
resulting in a two stage procedure if required.
They were asked to indicate their preference on a
scale of 0e10 (0¼ strongly disagree, 10¼ strongly
agree).
Results
We received 64 responses. Of these, 32 patients
had true negative, 29 true positive and 3 false
negative diagnoses on touch imprint cytology
(Table 1). A higher proportion of patients with
true positive diagnoses than true negative or false
negative diagnoses responded to the questionnaire
(c22¼ 7.17, p¼ 0.03).
There was good correlation (62/64¼ 97%) be-
tween patients’ understanding and the actual pro-
cedure performed. Patients’ score of the quantity
and quality of information provided was high
Table 1 Summary of the accuracy of intraoperative
diagnosis for responders and non-responders to
questionnaire
Response No response Total
True positive 29 7 36
True negative 32 25 57
False negative 3 4 7
Total 64 36 100
There is a significant difference between responders and
non-responders. c22¼ 7.17, p¼ 0.03.
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larly patients’ rating of their understanding of
the surgical procedure performed was high
(mean¼ 9.3/10, standard deviation¼ 1.1).
The majority of respondents (29/49¼ 59%) over-
estimated the sensitivity of intraoperative diagno-
sis (see Table 2). Thirty-nine percent (19/49) of
patients correctly estimated and 1 patient under-
estimated the sensitivity of touch imprint cytol-
ogy. Eight patients could not recall the sensitivity
and 7 patients did not answer the question.
Fig. 1 shows the range of scores for patients’
choice of sentinel node biopsy with or without
intraoperative diagnosis. We classified a score of
above 5 as agreement, below 5 as disagreement
and a score of 5 as indecision. Based on this, 95%
of respondents (57/60) would choose intraopera-
tive diagnosis if they had to undergo sentinel
node biopsy in the future. Five percent (3/60)
would prefer not to undergo intraoperative diagno-
sis (Table 3). Of these patients, 2 had true negative
diagnoses and 1 had a false negative diagnosis.
When asked to express their opinion on sentinel
node biopsy without intraoperative diagnosis, 22%
(12/54) of patients would agree to undergo a two
stage procedure, 74% (40/54) would disagree and
4% patients (2/54) were undecided. Ten respon-
dents did not answer this question. Some patients
indicated a high level of agreement with both
options, indicating by free text comments that
they would be prepared to be advised by their
medical team.
Selected extracts from free text comments in
favour and against intraoperative diagnosis are
listed in Table 4.
Discussion
Sentinel node biopsy is now well established as an
accurate technique for axillary staging in breast
Table 2 Patients’ estimation of the sensitivity of
intraoperative diagnosis (the true sensitivity at our
institution is 81%)
Estimated
sensitivity
Number of
patients
Percentage
(%)
>95% 29 59
>80% 19 39
>40% 1 2
<20% 0 0
Don’t know 8
Not answered 7
Total 64 100cancer with proven lower morbidity when com-
pared to conventional ALND.1e4 Intraoperative
diagnosis of sentinel nodes using either frozen
section or touch imprint cytology is a logical ap-
proach. It potentially avoids a second operative
procedure for ALND and facilitates earlier com-
mencement of adjuvant therapy for those patients
likely to benefit most.
While the rationale for intraoperative diagnosis
of sentinel nodes appears attractive, no previous
studies have evaluated patients’ views on this
issue. The patients’ comments listed in Table 4
give an interesting perspective. Intraoperative
diagnosis introduces uncertainty for the patient
at induction of anaesthesia as to the extent of sur-
gery to be performed. Since sentinel node biopsy
does not usually require surgical drainage, waking
to find a surgical drain implies both a more exten-
sive surgical procedure as well as worse prognosis
node-positive disease. The presence of a drain is,
in effect, breaking this bad news to the patient.
The psychological impact of this has not been
determined and this area remains a subject of
our research interest. It is interesting to note
that 2 of the 3 patients who would choose against
future intraoperative diagnosis had true negative
results. We acknowledge that a higher proportion
of patients with true positive than true negative
or false negative intraoperative diagnoses re-
sponded to this questionnaire, which may introduce
some bias to the results.
False negative intraoperative diagnosis is a rea-
son for further concern. This results in some
patients’ initial post-operative elation being re-
placed with disappointment when final histology
is available. Even the exhaustive intraoperative
frozen section methodology described by the
European Institute of Oncology has an imperfect
negative predictive value of 95.4%.5 The sensitivity
of routine frozen section and touch imprint cytol-
ogy is significantly lower. An unexpected false neg-
ative diagnosis may exaggerate the adverse
psychological effect. It is noteworthy that the ma-
jority of respondents within this study overesti-
mated the sensitivity of intraoperative diagnosis.
This is despite the high rating of adequacy of
pre-operative information and understanding of
surgery. This emphasizes the need to ensure that
patients understand the potential for a false nega-
tive result and have realistic expectations of what
can be achieved at their treating hospital. False
positive diagnoses have been reported for both
frozen section and touch imprint cytology, which
could lead to unnecessary extensive surgery
(ALND).6e8 There were no false positive diagnoses
in this study.
Patients’ view on intraoperative diagnosis of sentinel nodes in breast cancer 79Patient Preference for 2 Stage Operation
(No Intraoperative Diagnosis) n=54
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Score (0-Disagree 10-Strongly Agree)
P
e
r
c
e
n
t
a
g
e
Patient Preference for 1 Stage Operation
(Intraoperative Diagnosis) n=60
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Score (0=Disagree 10=Strongly Agree)
P
e
r
c
e
n
t
a
g
e
Figure 1 Distribution of level of agreement with sentinel node biopsy with intraoperative diagnosis (above) and
without intraoperative diagnosis (below). 0¼ strongly disagree & 10¼ strongly agree.Early results from the UK ALMANAC study have
shown heightened pre-operative anxiety in patients
undergoing sentinel node biopsy (though not signifi-
cantly different from patients undergoing ALND),
which returns to baseline post-operatively.2,9,4 This
anxietymaybeaccentuatedbyutilizing intraoperative
diagnosis, and should be prospectively studied.
Fallowfield et al. have shown that patient anxiety
is influenced by both information provision and
choice, which highlights the need for both thorough
Table 3 Patients’ level of agreement with sentinel
node biopsy with (left) and without (right) intraoper-
ative diagnosis
Sentinel node
biopsy with
intraoperative
diagnosis
Sentinel node
biopsy without
intraoperative
diagnosis
Agree (score> 5) 57/60 (95%) 12/54 (22%)
Undecided (score¼ 5) 0/60 (0%) 2/54 (4%)
Disagree (score< 5) 3/60 (5%) 40/54 (74%)pre-operative counselling and for patients to be
actively involved in decision making.10,11
Given the choice, the majority of patients
would prefer intraoperative diagnosis when un-
dergoing sentinel node biopsy for breast cancer.
Five percent of patients who responded to the
questionnaire in this study would, however, ex-
plicitly choose not to undergo intraoperative
examination, emphasizing the need to plan man-
agement on an individual basis. It is interesting to
note that some patients indicated high levels of
agreement for sentinel node biopsy both with and
without intraoperative diagnosis, with comments
indicating their desire to leave this choice up to
their operating surgeon.
Conclusion
This study demonstrates that patients overestimate
the sensitivity of intraoperative diagnosis, which
may accentuate the disappointment when a false
negative diagnosis occurs. The majority of patients
would choose intraoperative diagnosis though some
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diagnosis: selected free text comments in favour
(above) and against (below) intraoperative diagnosis
of sentinel nodes
Patients’ opinions in support of intraoperative
diagnosis
‘‘Why waste time?’’ (TP)
‘‘Prefer it all done at once e like me e One less
anaesthetic’’ (TP)
‘‘I feel a 2 stage operation delays the start of
treatment’’ (TP)
‘‘It made sense to me’’ (TN)
‘‘My understanding is, if it has to be removed, why
delay!’’ (TP)
‘‘Seems a sensible option. Preferred a single
operation’’ (TP)
‘‘Get it over with’’ (TN)
‘‘Having two (possible) operations rather than one
would seem to add stress and I imagine delay next
phase of treatment’’ (TN)
‘‘I feel no intraoperative diagnosis delays the start of
treatment and may cause a financial burden if you
are away from your job for too long if radiotherapy
and chemotherapy are required’’ (TP)
‘‘When I woke up with a big scar under my arm I was
very sad. I’m glad it was all done at the same
time e but the sentinel node biopsy gave me
hope which was dashed when I woke up.’’ (TP)
Patients’ opinions opposed to intraoperative
diagnosis
‘‘I would rather have time between the 2 op’s to think
and talk about the after effects of this. For me this
is important, as I had to come to terms with the
second diagnosis of the spread’’ (FN)
‘‘The uncertainty was quite distressing’’ (TP)
‘‘I was very disappointed when I woke to find a drain
and should have been better prepared
psychologically for this outcome’’ (TP)
The class of imprint cytology result corresponding with each
statement is given in parentheses (TP¼ true positive,
TN¼ true negative, FN¼ false negative).identify the disadvantages thereof, and would
explicitly decide against it. Intraoperative diagnosis
should therefore not be the automatic choice.
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